Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Nov 13, 2023

SELL
$1.77 - $2.38 $86,951 - $116,917
-49,125 Closed
0 $0
Q1 2023

Nov 13, 2023

SELL
$1.5 - $3.5 $1,050 - $2,450
-700 Reduced 1.4%
49,125 $112 Million
Q4 2022

Nov 13, 2023

SELL
$1.77 - $3.9 $2,301 - $5,070
-1,300 Reduced 2.54%
49,825 $101 Million
Q3 2022

Nov 13, 2023

SELL
$0.57 - $4.74 $570 - $4,740
-1,000 Reduced 1.92%
51,125 $171 Million
Q2 2022

Nov 13, 2023

SELL
$2.94 - $5.12 $16,199 - $28,211
-5,510 Reduced 9.56%
52,125 $153 Million
Q1 2022

Nov 13, 2023

BUY
$4.39 - $10.17 $7,901 - $18,306
1,800 Added 3.22%
57,635 $292 Million
Q4 2021

Nov 13, 2023

BUY
$9.89 - $13.83 $552,208 - $772,198
55,835 New
55,835 $593 Million

Others Institutions Holding RBOT

About Vicarious Surgical Inc.


  • Ticker RBOT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 102,592,000
  • Market Cap $580M
  • Description
  • Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massach...
More about RBOT
Track This Portfolio

Track Werlinich Asset Management, LLC Portfolio

Follow Werlinich Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Werlinich Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Werlinich Asset Management, LLC with notifications on news.